Ballwin, MO, United States of America

Joseph K McLaughlin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph K McLaughlin: Innovator in Recombinant Protein Manufacturing

Introduction: Joseph K McLaughlin is a notable inventor based in Ballwin, MO (US). He has made significant contributions to the field of biotechnology, particularly in the manufacturing of recombinant proteins. His innovative work has led to the development of advanced systems that enhance the efficiency of protein production.

Latest Patents: Joseph K McLaughlin holds 1 patent for his invention titled "Integrated and continuous recombinant protein manufacturing." This patent encompasses integrated systems and methods for the manufacturing of recombinant proteins in mammalian cells. The systems include a single-use bioreactor (SUB), a tangential flow filtration system, a column chromatography skid, a tankless hold, a virus inactivation plug flow reactor, and pumps.

Career Highlights: McLaughlin's career is marked by his dedication to advancing biomanufacturing processes. His work at Boehringer Ingelheim International GmbH has positioned him as a key player in the biotechnology sector. His innovative approaches have contributed to the efficiency and effectiveness of protein production.

Collaborations: Joseph K McLaughlin has collaborated with talented professionals in his field, including Jeffrey Richard Salm and Jonathan Coffman. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion: Joseph K McLaughlin's contributions to recombinant protein manufacturing exemplify the impact of innovation in biotechnology. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…